A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma.
Msaouel P, Sweis RF, Bupathi M, Heath E, Goodman OB Jr, Hoimes CJ, Milowsky MI, Davis N, Kalebasty AR, Picus J, Shaffer D, Mao S, Adra N, Yorio J, Gandhi S, Grivas P, Siefker-Radtke A, Yang R, Latven L, Olson P, Chin CD, Der-Torossian H, Mortazavi A, Iyer G.
Msaouel P, et al. Among authors: goodman ob jr.
Eur Urol Oncol. 2023 Dec 16:S2588-9311(23)00282-1. doi: 10.1016/j.euo.2023.12.001. Online ahead of print.
Eur Urol Oncol. 2023.
PMID: 38105142